Clinical trial
Phase II Trial of Sorafenib in Patients With Myelodysplastic Syndrome
NCT00510289 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial of Sorafenib in Patients With Myelodysplastic Syndrome
- Lead sponsor
- Duke University
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 31, 2006
- Completion date
- July 31, 2011
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.